Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
Kappa opioid receptor agonist/ mü antagonist providing analgesia, while preventing respiratory depression More
Non grease, petroleum free, 3 ways usage decongestant cream More
Opioid receptor antagonist reducing opioid induced respiratory depression More
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola. More
Spraying a tannin-rich hypertonic solution on the throat surface generates hypotonic fluid exudation, detaching all contaminants, hydrating the throat and alleviating the pain. Virus neutralization inhibits further infection. For adults and children. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 178 pages - $1,495
Nov 2011 - 7 pages - $3,835
Nov 2010 - 160 pages - $1,495
May 2011 - 81 pages - $3,835
Apr 2009 - 450 pages - $3,490
Dec 2010 - 71 pages - $1,000
Jan 2011 - 33 pages - $500
Jan 2011 - 28 pages - $1,000
Dec 2010 - 37 pages - $1,000
Jan 2011 - 22 pages - $500
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us